| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2022 | ISRG Intuitive Surgical Inc | Johnson Amal M60 | Director | Sell | 6,375 | $238.04 | $1,517,487.15 | -36.2% | +1.9% | +28.5% | |
| Aug 3, 2022 | NVCR Novocure Ltd | Benaim Ely73 | Chief Medical Officer | Sell | 5,959 | $73.73 | $439,327.67 | -8.7% | +0.7% | -60.0% | |
| Aug 3, 2022 | RMD Resmed Inc | Pendarvis David68 | Chief Administrative Officer | Sell | 1,545 | $240.72 | $371,912.40 | -1.4% | -7.6% | -7.8% | |
| Aug 3, 2022 | EKSO Ekso Bionics Holdings, Inc. | Wong Jerome55 | Interimchief Financial Officer | Sell | 1,675 | $1.80 | $3,021.37 | -1.6% | -8.8% | -38.5% | |
| Aug 3, 2022 | RSCF Reflect Scientific, Inc. | Boyce Kim | CEO, CFO | Buy | 25,000 | $0.12 | $2,997.50 | - | - | - | |
| Aug 3, 2022 | RGEN Repligen Corp | Bylund James70 | Chief Operating Officer | Sell | 2,000 | $240.40 | $480,800.00 | -17.0% | -22.8% | -29.7% | |
| Aug 3, 2022 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 4,600 | $20.03 | $92,138.00 | -11.3% | +17.4% | -8.2% | |
| Aug 2, 2022 | NEOG Neogen Corp | Green Ronald D | Director | Buy | 1,500 | $22.50 | $33,750.00 | +16.3% | -40.3% | +2.2% | |
| Aug 2, 2022 | NVCR Novocure Ltd | Doyle William F53 | Executive Chairman | Sell | 837 | $69.66 | $58,304.58 | -0.2% | +0.7% | -57.1% | |
| Aug 2, 2022 | MASS 908 Devices Inc. | Turner Michael S.75 | VP, General Counsel | Sell | 10,000 | $23.96 | $239,600.00 | -100% | -31.7% | -72.0% | |
| Aug 2, 2022 | EW Edwards Lifesciences Corp | Chopra Daveen59 | Cvp, Surgical Structural Heart | Sell | 1,000 | $102.49 | $102,490.00 | -5.0% | -29.1% | -21.4% | |
| Aug 2, 2022 | NVCR Novocure Ltd | Benaim Ely73 | Chief Medical Officer | Sell | 437 | $69.66 | $30,440.98 | -1.2% | +0.7% | -57.1% | |
| Aug 2, 2022 | BSX Boston Scientific Corp | Connors Nelda J | Director | Sell | 16,088 | $41.58 | $668,939.04 | -76.7% | +4.0% | +22.1% | |
| Aug 2, 2022 | NVCR Novocure Ltd | Leonard Frank X76 | Chief Development Officer | Sell | 414 | $69.66 | $28,838.83 | -0.4% | +0.7% | -57.1% | |
| Aug 2, 2022 | IART Integra Lifesciences Holdings Corp | Mosebrook Jeffrey70 | SVP, Fin &Princ Acct Officer | Sell | 437 | $56.78 | $24,810.68 | -4.7% | -10.1% | -20.4% | |
| Aug 2, 2022 | LAB Standard Biotools Inc. | Caligan Partners LP58 | 10% Owner | Buy | 620,466 | $1.54 | $953,649.68 | +1.9% | -30.6% | +47.6% | |
| Aug 1, 2022 | PEN Penumbra Inc | O'Rourke Bridget55 | Director | Sell | 88 | $137.12 | $12,066.56 | -2.2% | +21.5% | +111.4% | |
| Aug 1, 2022 | TMCI Treace Medical Concepts, Inc. | Owens Daniel E.52 | Chief Human Resources Officer | Sell | 1,000 | $16.89 | $16,890.40 | -8.5% | +43.7% | +28.7% | |
| Aug 1, 2022 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 30,000 | $20.00 | $600,000.00 | -9.3% | -20.8% | +3.8% | |
| Aug 1, 2022 | RGEN Repligen Corp | Snodgres Jon59 | Chief Financial Officer | Sell | 2,000 | $220.00 | $440,000.00 | -5.1% | -14.1% | -21.4% | |
| Aug 1, 2022 | Toloue Masoud57 | President &CEO | Sell | 446 | $15.61 | $6,964.16 | -0.5% | -27.1% | +64.3% | ||
| Aug 1, 2022 | BSX Boston Scientific Corp | Thepaut Eric Francis Yves | EVP &Pres, Eur, Mid-east, Afr | Sell | 20,676 | $40.99 | $847,509.24 | -22.2% | +5.0% | +26.4% | |
| Aug 1, 2022 | TELA Tela Bio, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 4,979 | $7.96 | $39,631.84 | +0.3% | +11.5% | +26.9% | |
| Aug 1, 2022 | Fry John J83 | General Counsel &Secretary | Sell | 401 | $15.61 | $6,261.49 | -1.1% | -27.1% | +64.3% | ||
| Aug 1, 2022 | CTKB Cytek Biosciences, Inc. | Jeanmonod Patrik77 | Chief Financial Officer | Sell | 3,500 | $12.80 | $44,800.00 | -3.6% | +21.2% | -30.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.